Literature DB >> 2690067

Regression of adjuvant-induced arthritis in rats following bone marrow transplantation.

D W van Bekkum1, E P Bohre, P F Houben, S Knaan-Shanzer.   

Abstract

Total body irradiation followed by bone marrow transplantation was found to be an effective treatment for adjuvant arthritis induced in rats. This treatment is most effective when applied shortly after the clinical manifestation of arthritis--i.e., 4-7 weeks after administration of Mycobacterium tuberculosis. Transplantation of bone marrow at a later stage results in a limited recovery, in that the inflammatory reaction regresses but the newly formed excessive bone is not eliminated. Local irradiation of the affected joints had no effect on the disease. It could also be excluded that the recovery of arthritis following marrow transplantation is due to lack of available antigen. Transplantation of syngeneic bone marrow is as effective as that of allogeneic bone marrow from a rat strain that is not susceptible to induction of adjuvant arthritis. The beneficial effect of this treatment cannot be ascribed to the immunosuppressive effect of total body irradiation, since treatment with the highly immunosuppressive drug Cyclosporin A resulted in a regression of the joint swelling but relapse occurred shortly after discontinuation of the treatment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2690067      PMCID: PMC298650          DOI: 10.1073/pnas.86.24.10090

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Studies of arthritis and other lesions induced in rats by the injection of mycobacterial adjuvant. VII. Pathologic details of the arthritis and spondylitis.

Authors:  C M PEARSON; F D WOOD
Journal:  Am J Pathol       Date:  1963-01       Impact factor: 4.307

2.  Biology of the human histocompatibility leukocyte antigen (HLA) system and a hypothesis regarding the generation of autoimmune diseases.

Authors:  J L Strominger
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

Review 3.  Major histocompatibility gene complex-disease associations may reflect T cell-mediated immunopathology.

Authors:  R M Zinkernagel
Journal:  Eur J Clin Invest       Date:  1986-04       Impact factor: 4.686

4.  Histopathology of arthritis induced in rats by active immunization to mycobacterial antigens or by systemic transfer of T lymphocyte lines. A light and electron microscopic study of the articular surface using cationized ferritin.

Authors:  R Stanescu; O Lider; W van Eden; J Holoshitz; I R Cohen
Journal:  Arthritis Rheum       Date:  1987-07

5.  Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemia.

Authors:  P Jacobs; M D Vincent; R W Martell
Journal:  Bone Marrow Transplant       Date:  1986-12       Impact factor: 5.483

Review 6.  Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships.

Authors:  S Strober
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

7.  Remission of rheumatoid arthritis with the successful treatment of acute myelogenous leukemia with cytosine arabinoside, daunorubicin, and m-AMSA.

Authors:  R Roubenoff; R J Jones; J E Karp; M B Stevens
Journal:  Arthritis Rheum       Date:  1987-10

8.  A cross-reactive idiotype on anti-collagen antibodies in collagen-induced arthritis: identification and relevance to disease.

Authors:  C Nagler-Anderson; R F van Vollenhoven; M F Gurish; L A Bober; G W Siskind; G J Thorbecke
Journal:  Cell Immunol       Date:  1988-05       Impact factor: 4.868

9.  Total lymphoid irradiation of intractable rheumatoid arthritis.

Authors:  M Herbst; H Fritz; R Sauer
Journal:  Br J Radiol       Date:  1986-12       Impact factor: 3.039

10.  Long-term followup of rheumatoid arthritis patients treated with total lymphoid irradiation.

Authors:  A Tanay; E H Field; R T Hoppe; S Strober
Journal:  Arthritis Rheum       Date:  1987-01
View more
  21 in total

Review 1.  Stem cell transplantation for autoimmune diseases.

Authors:  J Moore; P Brooks
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  The potential role of adult stem cells in the management of the rheumatic diseases.

Authors:  Tiziana Franceschetti; Cosimo De Bari
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-04-20       Impact factor: 5.346

Review 3.  Adult stem cell therapy for autoimmune disease.

Authors:  Eun Wha Choi
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

Review 4.  Optimisation of cyclophosphamide therapy in systemic vasculitis.

Authors:  R Richmond; T W McMillan; R A Luqmani
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

5.  Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation.

Authors:  Marco Capobianco; Y Motuzova; J Frau; E Cocco; E Mamusa; M G Marrosu; A Bertolotto
Journal:  Neurol Sci       Date:  2011-11-25       Impact factor: 3.307

Review 6.  Prospects of immunotherapy for rheumatoid arthritis.

Authors:  B A t Hart; H G Otten
Journal:  Pharm World Sci       Date:  1995-11-24

7.  Modality comparison for small animal radiotherapy: a simulation study.

Authors:  Magdalena Bazalova; Geoff Nelson; John M Noll; Edward E Graves
Journal:  Med Phys       Date:  2014-01       Impact factor: 4.071

Review 8.  Stem cell transplantation in experimental models of autoimmune disease.

Authors:  D W van Bekkum
Journal:  J Clin Immunol       Date:  2000-01       Impact factor: 8.317

9.  Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation.

Authors:  D M Karussis; U Vourka-Karussis; D Lehmann; H Ovadia; R Mizrachi-Koll; A Ben-Nun; O Abramsky; S Slavin
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

Review 10.  [Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus].

Authors:  T Alexander; R Arnold; F Hiepe
Journal:  Z Rheumatol       Date:  2016-10       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.